Ross Leimberg
Direktor-Back Office Betrieb bei Resilience Biotechnologies, Inc.
Profil
Ross Leimberg is currently the Senior Director-Business Development at Resilience Biotechnologies, Inc. He previously worked as a Board Observer at CTx Operations, Inc., Palleon Pharmaceuticals, Inc., and Accelerator Life Science Partners II LP.
Mr. Leimberg earned an MBA degree from Harvard Business School in 2012.
Aktive Positionen von Ross Leimberg
| Unternehmen | Position | Beginn |
|---|---|---|
Resilience Biotechnologies, Inc.
 Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Direktor-Back Office Betrieb | 01.01.2021 |
Ehemalige bekannte Positionen von Ross Leimberg
| Unternehmen | Position | Ende |
|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 31.12.2021 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 31.12.2021 |
Accelerator Life Science Partners II LP
 Accelerator Life Science Partners II LP Investment ManagersFinance Part of Accelerator Services Corp, Accelerator Life Science Partners II LP functions as a venture capital fund. The company is based in Seattle, WA. | Direktor/Vorstandsmitglied | 02.01.2021 |
Ausbildung von Ross Leimberg
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Commercial Services |
Accelerator Life Science Partners II LP
Accelerator Life Science Partners II LP Investment ManagersFinance Part of Accelerator Services Corp, Accelerator Life Science Partners II LP functions as a venture capital fund. The company is based in Seattle, WA. | Finance |
Resilience Biotechnologies, Inc.
Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | Health Technology |
